Living, an umbrella brand of Wing specialising in residential properties, has completed the first phase of its Park West project offering 229 apartments in District 13 of Budapest. About 700 apartments will be constructed in the residential development project to be carried out in three phases.
Living has completed the first phase of Park West residential development with 97% of its apartments already sold. There are 229 apartments in Park West 1 residential park, all with a BB energy efficiency rating. Park West residential park is located in one of the fastest developing areas of Budapest, in the Ferdinánd quarter of District 13, at Szabolcs utca 15-25.
“Within the framework of Living’s development project, we were able to create a community residential park providing unique services to enhance the comfort of the residential community. Park West 1 has been extremely popular among fans of an active city lifestyle and 97% of the sunny apartments with terraces have already found their owners. Demand is still high thanks to the excellent location, comfortable and energy-efficient apartments, and the community spaces created in the houses in order to make daily life even more convenient for residents”, said János Martin, Living’s branch director.
Each apartment has a terrace/balcony and a parking space in the underground garage available for all the apartments. Separate storage units were also created on each floor of the house. Park West 1’s community living room offers residents co-working office space, as well as relevant business corner services. Other services available include a library, a cleaning service, a toolshed, car-sharing services and a 24/7 parcel delivery point.
Each Park West 1 home will be fitted with smart solutions. The Smart Home package includes, at no cost, a central unit, smart sockets, free WiFi service and heating controls. The optional Smart+ package, available for an extra charge, includes additional amenities.
The construction of Park West 2 also started last year. It is scheduled for completion in the first half of 2023.